Evidence map›Paper›PMID 35598083›Full record

ReviewJournal of neuroimaging : official journal of the American Society of Neuroimaging2022

Functional MRI in major depressive disorder: A review of findings, limitations, and future prospects.

Jesper Pilmeyer, Willem Huijbers, Rolf Lamerichs, Jacobus F A Jansen, Marcel Breeuwer, Svitlana Zinger

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Ecologically-Valid Emotion Signatures Enhance Mood Disorder Diagnostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jesper PilmeyerDepartment of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.ORCID 0000-0002-8419-8207
Willem HuijbersDepartment of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.ORCID 0000-0003-3958-4069
Rolf LamerichsDepartment of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Jacobus F A JansenDepartment of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.ORCID 0000-0002-5271-8060
Marcel BreeuwerPhilips Healthcare, Best, The Netherlands.ORCID 0000-0003-1822-8970
Svitlana ZingerDepartment of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Philips (Netherlands) · NLKempenhaeghe · NLMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective diagnosis and prognosis in major depressive disorder (MDD) remains a challenge due to the absence of biomarkers based on physiological parameters or medical tests. Numerous studies have been conducted to identify functional magnetic resonance imaging-based biomarkers of depression that either objectively differentiate patients with depression from healthy subjects, predict personalized treatment outcome, or characterize biological subtypes of depression. While there are some findings of consistent functional biomarkers, there is still lack of robust data acquisition and analysis methodology. According to current findings, primarily, the anterior cingulate cortex, prefrontal cortex, and default mode network play a crucial role in MDD. Yet, there are also less consistent results and the involvement of other regions or networks remains ambiguous. We further discuss image acquisition, processing, and analysis limitations that might underlie these inconsistencies. Finally, the current review aims to address and discuss possible remedies and future opportunities that could improve the search for consistent functional imaging biomarkers of depression. Novel acquisition techniques, such as multiband and multiecho imaging, and neural network-based cleaning approaches can enhance the signal quality in limbic and frontal regions. More comprehensive analyses, such as directed or dynamic functional features or the identification of biological depression subtypes, can improve objective diagnosis or treatment outcome prediction and mitigate the heterogeneity of MDD. Overall, these improvements in functional MRI imaging techniques, processing, and analysis could advance the search for biomarkers and ultimately aid patients with MDD and their treatment course.

Indexed as

Major Depressive DisorderBrainBrain MappingGyrus CinguliHumansMagnetic Resonance ImagingNeural PathwaysPrefrontal Cortexbiomarkersmajor depressive disorderMRIreview

Identifiers

PMID35598083
PMCPMC9540243
OpenAlexW4281264024

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.